abiraterone has been researched along with ranitidine in 1 studies
Studies (abiraterone) | Trials (abiraterone) | Recent Studies (post-2010) (abiraterone) | Studies (ranitidine) | Trials (ranitidine) | Recent Studies (post-2010) (ranitidine) |
---|---|---|---|---|---|
942 | 97 | 854 | 85 | 0 | 29 |
Protein | Taxonomy | abiraterone (IC50) | ranitidine (IC50) |
---|---|---|---|
Potassium-transporting ATPase alpha chain 1 | Homo sapiens (human) | 0.04 | |
Acetylcholinesterase | Homo sapiens (human) | 1.475 | |
Potassium-transporting ATPase subunit beta | Homo sapiens (human) | 0.04 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 8.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
1 other study(ies) available for abiraterone and ranitidine
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |